approval · primary record
RITUXIMAB-ARRX
FDA · BLA · 2026-09-29
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-09-29 |
| Brand | RIABNI |
| Sponsor | AMGEN INC |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:12.635Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:RITUXIMAB-ARRX:2026-09-29
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.